Loading…
OGI
Organigram Global Inc
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 68617J100
$1.22-1.22%Price as of Aug 29, 18:37 UTC · updated once a day, after the close
Key metrics
- Market cap
- $171.32M
- P/E
- 2.8x
- Forward P/E
- 50.6x
- P/B
- 0.5x
- Dividend yield
- —
- Payout
- —
- EPS
- $0.43
- ROE
- 17.56%
- Profit margin
- 28.02%
- Revenue growth
- +49.40%
- Beta
- —
- 52-week high
- $2.24
- 52-week low
- $0.85
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -87.6% over 5Y.
today you would have $119.57▼ -88.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|---|
| Year-end price | $1.68 | $1.61 | $3.20 | $7.00 | |
| P/S | 1.4x | 0.9x | 1.1x | 1.7x | 6.6x |
| P/B | 0.6x | 0.6x | 0.6x | 0.5x | 1.1x |
| EPS | -$0.19 | -$0.48 | -$0.19 | -$2.04 | |
| Profit margin | -19.11% | -9.55% |
Fair price, seven ways
Seven formulas applied to what the company reported. None of them predicts a price — each answers what the stock would be worth if its assumption held. The assumption is printed next to every number, because it is the assumption that produces the result.
Earnings
$5.01
Square root of 22.5 × earnings × book value — the two ceilings Graham proposed. Blind to intangibles, so it undervalues software and brands.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
$9.64
Median P/E of 22.4 among peers in the sector.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Operating
$0.41
Sector median of 13.3x operating profit, less net debt. Sees the business before its financing, so debt does not distort the comparison. Banks have no EBITDA — interest is their revenue, not a cost.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| LFCRLifecore Biomedical Inc de | $4.54 | — | — | — | — | $171.85M |
| QSIQuantum-Si Inc | $0.78 | — | 0.9x | — | -49.11% | $170.73M |
| MOLNMolecular Partners AG | $4.50 | — | 2.4x | — | -61.97% | $172.37M |
| ZJYLJin Medical International Ltd. | $2.34 |
About the company
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
- 1,139
- Toronto, Canada
Company description provided by Yahoo Finance.